These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 25051712)
1. [Treatment approaches for bronchopulmonary infection in myasthenia gravis patients]. Sokolova VI; Sanadze AG; Sychev DA; Babarina MB; Zaĭkov DA Antibiot Khimioter; 2014; 59(1-2):20-3. PubMed ID: 25051712 [TBL] [Abstract][Full Text] [Related]
2. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam]. Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338 [TBL] [Abstract][Full Text] [Related]
3. [Comparative estimation of the application efficacy for ceftriaxon and Hepacef combi preparations in the abdominal infection treatment]. Boĭko VV; Ivanova IuV Klin Khir; 2012 Jan; (1):30-2. PubMed ID: 22642085 [TBL] [Abstract][Full Text] [Related]
4. [Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital]. Antibiot Khimioter; 2006; 51(1):14-7. PubMed ID: 16734360 [TBL] [Abstract][Full Text] [Related]
5. [Sulperazone in the treatment of severe infections in patients with cancer]. Mitrokhin SD Antibiot Khimioter; 2003; 48(3):26-9. PubMed ID: 12914118 [TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam. Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process]. Semykin SIu; Postnikov SS; Polikarpova SV; Perederko LV Antibiot Khimioter; 2003; 48(12):18-21. PubMed ID: 15176099 [TBL] [Abstract][Full Text] [Related]
8. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India. Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578 [TBL] [Abstract][Full Text] [Related]
9. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia. Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and bacteriological substantiation of the use of cefoperazone/sulbactam in complex therapy of patients with pyo-destructive forms of lower respiratory tract infection (LRTI)]. Ovsiankin AV; Mukonin AA Antibiot Khimioter; 2004; 49(6):25-9. PubMed ID: 15628799 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis]. Zhou XS; Zou SQ; Dong JH; Wu WZ; Zhang YD; Zhang TL; Zeng Z; Li NF; Man GT Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1879-82. PubMed ID: 15631798 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting. Kochhar P; Suvarna V; Duttagupta S; Sarkar S Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065 [TBL] [Abstract][Full Text] [Related]
13. [Activity of cefoperazone and cefoperazone-sulbactam against gram-positive and gram-negative bacteria]. Baykal M; Hasçelik G Mikrobiyol Bul; 1990 Oct; 24(4):383-5. PubMed ID: 2287298 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Chetchotisakd P; Porramatikul S; Mootsikapun P; Anunnatsiri S; Thinkhamrop B Clin Infect Dis; 2001 Jul; 33(1):29-34. PubMed ID: 11389491 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model. Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626 [TBL] [Abstract][Full Text] [Related]
17. Use of cefoperazone/sulbactam in neonates. Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia. Klekner A; Bagyi K; Bognar L; Gaspar A; Andrasi M; Szabo J J Clin Microbiol; 2006 Sep; 44(9):3418-21. PubMed ID: 16954290 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children]. Huang JJ; Zeng Q; Yu JL Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1199-200. PubMed ID: 16174597 [TBL] [Abstract][Full Text] [Related]
20. [Use of a combination of cefoperazone with sulbactam for treatment of patients with wound infections]. Iakovlev VP; Blatun LA; Puchkova LS; Svetukhin AM Antibiot Khimioter; 1994 Dec; 39(12):31-4. PubMed ID: 7733785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]